Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type
ContributorsPopp, Julius; Wolfsgruber, Steffen; Heuser, Isabella; Peters, Oliver; Hüll, Michael; Schröder, Johannes; Möller, Hans-Jürgen; Lewczuk, Piotr; Schneider, Anja; Jahn, Holger; Luckhaus, Christian; Perneczky, Robert; Frölich, Lutz; Wagner, Michael; Maier, Wolfgang; Wiltfang, Jens; Kornhuber, Johannes; Jessen, Frank
Published inNeurobiology of Aging, vol. 36, no. 2, p. 601-607
Publication date2015
Abstract
Keywords
- Aged
- Alzheimer Disease/blood/cerebrospinal fluid/diagnosis/physiopathology
- Amyloid beta-Peptides/cerebrospinal fluid
- Biomarkers/blood/cerebrospinal fluid
- Cognitive Dysfunction/blood/cerebrospinal fluid/diagnosis/physiopathology
- Cross-Sectional Studies
- Disease Progression
- Female
- Follow-Up Studies
- Humans
- Hydrocortisone/blood/cerebrospinal fluid
- Hypothalamo-Hypophyseal System/physiopathology
- Longitudinal Studies
- Male
- Middle Aged
- Peptide Fragments/cerebrospinal fluid
- Pituitary-Adrenal System/physiopathology
- tau Proteins/cerebrospinal fluid
Affiliation Not a UNIGE publication
Citation (ISO format)
POPP, Julius et al. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer’s type. In: Neurobiology of Aging, 2015, vol. 36, n° 2, p. 601–607. doi: 10.1016/j.neurobiolaging.2014.10.031
Main files (1)
Article (Published version)
Identifiers
- PID : unige:106608
- DOI : 10.1016/j.neurobiolaging.2014.10.031
- PMID : 25435336
ISSN of the journal0197-4580